These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 27104494)
1. Will HPV vaccination affect cervical cancer morbidity and mortality world-wide? Luckett R; Feldman S Hum Vaccin Immunother; 2016 Jun; 12(6):1373-4. PubMed ID: 27104494 [No Abstract] [Full Text] [Related]
2. Mathematical models of cervical cancer prevention in the Asia Pacific region. Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411 [TBL] [Abstract][Full Text] [Related]
3. Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness? de Kok IM; Habbema JD; van Rosmalen J; van Ballegooijen M Eur J Cancer; 2011 Feb; 47(3):428-35. PubMed ID: 20971633 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report. de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764 [No Abstract] [Full Text] [Related]
5. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium. Demarteau N; Van Kriekinge G; Simon P Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952 [TBL] [Abstract][Full Text] [Related]
6. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES]. Malinova M Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767 [TBL] [Abstract][Full Text] [Related]
7. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]. Schneider A; Schwarz TF; Hammerschmidt T; Siebert U Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccines: who will pay, who will receive, when to administer? Saslow D; Wheeler CM Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157 [TBL] [Abstract][Full Text] [Related]
10. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Schiffman M Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850 [TBL] [Abstract][Full Text] [Related]
11. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses]. Westra TA; Daemen T; Postma MJ; Wilschut JC Ned Tijdschr Geneeskd; 2009; 153():A356. PubMed ID: 19930733 [TBL] [Abstract][Full Text] [Related]
12. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822 [TBL] [Abstract][Full Text] [Related]
13. Harnessing the power of prevention: human papillomavirus vaccines. Mayeaux EJ Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680 [TBL] [Abstract][Full Text] [Related]
14. Global Delivery of Human Papillomavirus Vaccines. Wigle J; Fontenot HB; Zimet GD Pediatr Clin North Am; 2016 Feb; 63(1):81-95. PubMed ID: 26613690 [TBL] [Abstract][Full Text] [Related]
15. HPV vaccines: too soon to detect an impact on mortality. Prescrire Int; 2016 Nov; 25(176):268. PubMed ID: 30730123 [No Abstract] [Full Text] [Related]
16. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia. Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299 [TBL] [Abstract][Full Text] [Related]
17. Prevention of HPV disease burden. Lehtinen M; Nieminen P; Apter D; Paavonen J Womens Health (Lond); 2014 Jul; 10(4):341-3. PubMed ID: 25259894 [No Abstract] [Full Text] [Related]
18. HPV vaccine in Rwanda: different disease, same double standard. Binagwaho A; Wagner CM; Nutt CT Lancet; 2011 Dec; 378(9807):1916. PubMed ID: 22137840 [No Abstract] [Full Text] [Related]
19. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL; Coutlée F; Ferenczy A Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic HPV vaccination for the prevention of cervical cancer. Hernandez BY Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858 [No Abstract] [Full Text] [Related] [Next] [New Search]